Latest Breaking News On - Prnewswire karyopharm therapeutics inc - Page 4 : comparemela.com

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass., Dec. 1, 2023 /PRNewswire/ Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an.

China
United-kingdom
Linkedin
Prnewswire-karyopharm-therapeutics-inc
Karyopharm-therapeutics-inc
Selective-inhibitor-of-nuclear-export
Nasdaq
Stock-incentive-plan
Nasdaq-listing-rule
Selective-inhibitor
Nuclear-export

Karyopharm to Participate at Upcoming Investor Conferences

/PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that.

London
City-of
United-kingdom
China
Piper-sandler
Prnewswire-karyopharm-therapeutics-inc
Selective-inhibitor-of-nuclear-export
Karyopharm-therapeutics-inc
Linkedin
Nasdaq
Annual-healthcare
Selective-inhibitor

Karyopharm Announces New Preliminary Data in Overall Survival (OS) in Selinexor-Treated Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer as Part of Pre-Specified Exploratory Subgr

Karyopharm Announces New Preliminary Data in Overall Survival (OS) in Selinexor-Treated Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer as Part of Pre-Specified Exploratory Subgr
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Singapore
Germany
South-korea
Italy
Rome
Lazio
Canada
Austria
Hong-kong

Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Israel
Boston
Massachusetts
United-states
United-kingdom
South-korea
China
Tsadal
Kyongsang-bukto
Bristol-myers-squibb
Richard-paulson
Exchange-commission

Karyopharm Announces Presentations at the 65th American Society of Hematology Annual Meeting and Exposition (ASH)

/PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that.

South-korea
United-kingdom
San-diego
California
United-states
Australia
China
Tsadal
Kyongsang-bukto
Israel
Singapore
Boston